von Tobias Borgers | Okt. 5, 2022 | Abbvie
AbbVie Deutschland GmbH & Co. KG Wiesbaden (ots) Das forschende BioPharma-Unternehmen AbbVie Deutschland ist mit dem „Corporate Health Award 2021“ und damit als Unternehmen mit dem besten betrieblichen Gesundheitsmanagement innerhalb der Chemie- und...
von Tobias Borgers | Sep. 12, 2022 | Abbvie
The 480,000 square-foot facility will put all our cross-functional experts in the Bay Area under one roof, opening up more opportunities for collaboration and innovation in oncology research and development.“Today, our scientists and colleagues in South San Francisco...
von Tobias Borgers | Apr. 13, 2022 | Abbvie
The 480,000 square-foot facility will put all our cross-functional experts in the Bay Area under one roof, opening up more opportunities for collaboration and innovation in oncology research and development.“Today, our scientists and colleagues in South San Francisco...
von Tobias Borgers | Sep. 14, 2021 | Abbvie
Copenhagen, Denmark; North Chicago, Ill. – Genmab A/S (Nasdaq: GMAB) and AbbVie (NYSE: ABBV) announced The Lancet published the results of the dose escalation part of the phase 1/2 EPCORE NHL-1 first-in-human (FIH) dose escalation and cohort expansion clinical...
von Tobias Borgers | März 8, 2021 | Abbvie
March 8, 2021 (Reports and Markets) “Online Pharmaceutical Market is growing at a High CAGR during the forecast period 2021-2027”. The report on the Online Pharmaceutical market provides a market analysis complete with a quantitative and qualitative assessment. The...
von Tobias Borgers | Nov. 28, 2020 | Abbvie
The Bio-pharma Market Status and Trend Market study is a perfect mix of qualitative and quantitative information and to get better understanding on how stats relates to growth, market sizing and share, the study is started with market overview and further detailed...
